Head of Department at SDU Sønderborg receives "The Funen Nobel Prize"

The Head of the Mads Clausen Institute at the University of Southern Denmark in Sønderborg, Horst-Günter Rubahn, received a great honour on Thursday when he was awarded Fyens Stiftstidende's Researcher Prize 2017.

Guests celebrated with champagne and wreath cake as Fyens Stiftstidende's Researcher Prize was awarded. The recipients were Head of Research Janne Clemmesen, Professor Søren Askegaard and Horst-Günter Rubahn, who is the first in the prize's 45 year history not to be based on the island of Funen.

Professor Horst-Günter Rubahn is Head of the Mads Clausen Institute in Sønderborg, where research is carried out on nanotechnology. He regards the prize, which is commonly referred to as "The Funen Nobel Prize", as a stamp of approval on his and the Mads Clausen Institute's work.

- I'm very pleased that Southern Jutland is now also represented   among the researchers to have been awarded Fyens     Stiftstidende's Researcher Prize, says Horst-Günter Rubahn.

The prize is accompanied by a cheque of 25,000 DKK, which he is thinking of using to hold a party at the nanotechnology centre NanoSYD. At the award ceremony, Horst-Günter Rubahn explained about the rapid development nanotechnology is undergoing. For although nanotechnology deals with some of science's smallest units (a nanometre is a millionth of a millimetre), the research will have a great influence on our future.

- We are working on making current technology both cheaper and   more energy efficient, and we're also working towards better global health.

Horst-Günter Rubahn is a particularly active researcher with over 500 publications to his name, including more than 200 critical articles and 10 books.Currently, he and his research team are involved in several groundbreaking projects working with regional companies and German universities. One of the projects has the aim of developing new diagnostic methods in the treatment of cancer, which will make it possible for doctors to determine as early as during an operation whether a tumor has been completely removed.